Filament Health Statistics

Total Valuation

Filament Health has a market cap or net worth of CAD 7.16 million. The enterprise value is 7.25 million.

Market Cap	7.16M
Enterprise Value	7.25M

Important Dates

The last earnings date was Thursday, August 14, 2025.

Earnings Date	Aug 14, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	261.79M
Shares Outstanding	n/a
Shares Change (YoY)	+25.20%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	110.68M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	15.30
PB Ratio	6.70
P/TBV Ratio	11.75
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-1.63
EV / Sales	15.45
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-4.96

Financial Position

The company has a current ratio of 0.45, with a Debt / Equity ratio of 0.45.

Current Ratio	0.45
Quick Ratio	0.44
Debt / Equity	0.45
Debt / EBITDA	n/a
Debt / FCF	-0.33
Interest Coverage	-34.90

Financial Efficiency

Return on equity (ROE) is -208.81% and return on invested capital (ROIC) is -82.27%.

Return on Equity (ROE)	-208.81%
Return on Assets (ROA)	-52.80%
Return on Invested Capital (ROIC)	-82.27%
Return on Capital Employed (ROCE)	-240.01%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	13
Asset Turnover	0.12
Inventory Turnover	n/a

Taxes

Income Tax	-12,173
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -81.82% in the last 52 weeks. The beta is 0.91, so Filament Health's price volatility has been similar to the market average.

Beta (5Y)	0.91
52-Week Price Change	-81.82%
50-Day Moving Average	0.02
200-Day Moving Average	0.03
Relative Strength Index (RSI)	38.54
Average Volume (20 Days)	212,706

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Filament Health had revenue of CAD 468,051 and -4.44 million in losses. Loss per share was -0.02.

Revenue	468,051
Gross Profit	468,051
Operating Income	-3.34M
Pretax Income	-4.45M
Net Income	-4.44M
EBITDA	-3.33M
EBIT	-3.34M
Loss Per Share	-0.02

Full Income Statement

Balance Sheet

The company has 679,972 in cash and 477,276 in debt, giving a net cash position of 202,696.

Cash & Cash Equivalents	679,972
Total Debt	477,276
Net Cash	202,696
Net Cash Per Share	n/a
Equity (Book Value)	1.07M
Book Value Per Share	0.00
Working Capital	-987,869

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -1.45 million and capital expenditures -13,729, giving a free cash flow of -1.46 million.

Operating Cash Flow	-1.45M
Capital Expenditures	-13,729
Free Cash Flow	-1.46M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	100.00%
Operating Margin	-712.94%
Pretax Margin	-951.30%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Filament Health does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-25.20%
Shareholder Yield	n/a
Earnings Yield	-61.99%
FCF Yield	-20.42%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Filament Health has an Altman Z-Score of -17.29 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-17.29
Piotroski F-Score	1